{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:09:46Z","timestamp":1780308586983,"version":"3.54.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10384-025-01313-0","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:32:07Z","timestamp":1765333927000},"page":"685-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse bilateral macular edema associated with omidenepag isopropyl in phakic eyes after laser iridotomy: a case report"],"prefix":"10.1007","volume":"70","author":[{"given":"Do Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8197-678X","authenticated-orcid":false,"given":"Ji Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(14)62347-3","volume":"385","author":"A Heijl","year":"2015","unstructured":"Heijl A. Glaucoma treatment: by the highest level of evidence. Lancet. 2015;385:1264\u20136.","journal-title":"Lancet"},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901\u201311.","journal-title":"JAMA"},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(16)30956-4","volume":"388","author":"A Azuara-Blanco","year":"2016","unstructured":"Azuara-Blanco A, Burr J, Ramsay C, Cooper D, Foster PJ, Friedman DS, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388:1389\u201397.","journal-title":"Lancet"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2015.10.049","volume":"123","author":"BE Prum","year":"2016","unstructured":"Prum BE, Herndon LW, Moroi SE, Mansberger SL, Stein JD, Lim MC, et al. Primary angle closure preferred practice pattern\u00ae guidelines. Ophthalmology. 2016;123:P1-40.","journal-title":"Ophthalmology"},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajo.2020.06.003","volume":"220","author":"M Aihara","year":"2020","unstructured":"Aihara M, Lu F, Kawata H, Iwata A, Odani-Kawabata N, Shams NK. Omidenepag isopropyl versus latanoprost in primary open-angle glaucoma and ocular hypertension: the phase 3 AYAME study. Am J Ophthalmol. 2020;220:53\u201363.","journal-title":"Am J Ophthalmol"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s10384-022-00934-z","volume":"66","author":"K Ueda","year":"2022","unstructured":"Ueda K, Sakata R, Fujishiro T, Honjo M, Shirato S, Aihara M. Newly or switching effect of a selective EP2 agonist on intraocular pressure in Japanese patients with open-angle glaucoma. Jpn J Ophthalmol. 2022;66:434\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s10384-020-00748-x","volume":"64","author":"M Aihara","year":"2020","unstructured":"Aihara M, Ropo A, Lu F, Kawata H, Iwata A, Odani-Kawabata N, et al. Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-\/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study. Jpn J Ophthalmol. 2020;64:398\u2013406.","journal-title":"Jpn J Ophthalmol"},{"key":"1313_CR9","volume":"12","author":"S Oogi","year":"2020","unstructured":"Oogi S, Nakakura S, Terao E, Fujisawa Y, Tabuchi H, Kiuchi Y. One-year follow-up study of changes in prostaglandin-associated periorbital syndrome after switch from conventional prostaglandin F2alfa to omidenepag isopropyl. Cureus. 2020;12:e10064.","journal-title":"Cureus"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ajo.2021.12.011","volume":"237","author":"K Inoue","year":"2022","unstructured":"Inoue K, Shiokawa M, Katakura S, Tsuruoka M, Kunimatsu-Sanuki S, Shimizu K, et al. Periocular adverse reactions to omidenepag isopropyl. Am J Ophthalmol. 2022;237:114\u201321.","journal-title":"Am J Ophthalmol"},{"key":"1313_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10384-021-00855-3","volume":"65","author":"R Sakata","year":"2021","unstructured":"Sakata R, Fujishiro T, Saito H, Nakamura N, Honjo M, Shirato S, et al. Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis. Jpn J Ophthalmol. 2021;65:591\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s10384-021-00868-y","volume":"65","author":"M Aihara","year":"2021","unstructured":"Aihara M, Lu F, Kawata H, Iwata A, Odani-Kawabata N. Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study. Jpn J Ophthalmol. 2021;65:810\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1272\/jnms.JNMS.2021_88-520","volume":"88","author":"K Nakamoto","year":"2021","unstructured":"Nakamoto K, Shiratori N, Nishio Y, Sugimoto S, Takano Y, Yamazaki M, et al. Cystoid macular edema associated with omidenepag isopropyl in phakic eyes after laser iridotomy: a case report. J Nippon Med Sch. 2021;88:506\u20138.","journal-title":"J Nippon Med Sch"},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12886-023-03091-0","volume":"23","author":"B-J Bae","year":"2023","unstructured":"Bae B-J, Kang EM, Lee SY. Cystoid macular edema associated with omidenepag isopropyl in a phakic eye with an implantable collamer lens: a case report. BMC Ophthalmol. 2023;23:334.","journal-title":"BMC Ophthalmol"},{"issue":"11\u201321","key":"1313_CR15","volume":"147","author":"MW Johnson","year":"2009","unstructured":"Johnson MW. Etiology and treatment of macular edema. Am J Ophthalmol. 2009;147(11\u201321):e1.","journal-title":"Am J Ophthalmol"},{"key":"1313_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109691","volume":"237","author":"N Nakamura","year":"2023","unstructured":"Nakamura N, Honjo M, Yamagishi R, Sakata R, Watanabe S, Aihara M. Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia. Exp Eye Res. 2023;237:109691.","journal-title":"Exp Eye Res"},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0161-6420(99)00528-X","volume":"106","author":"SE Moroi","year":"1999","unstructured":"Moroi SE, Gottfredsdottir MS, Schteingart MT, Elner SG, Lee CM, Schertzer RM, et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology. 1999;106:1024\u20139.","journal-title":"Ophthalmology"},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"ii24","DOI":"10.1136\/bjophthalmol-2014-305305","volume":"98","author":"G Trichonas","year":"2014","unstructured":"Trichonas G, Kaiser PK. Optical coherence tomography imaging of macular oedema. Br J Ophthalmol. 2014;98:ii24\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","volume":"127","author":"T Otani","year":"1999","unstructured":"Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127:688\u201393.","journal-title":"Am J Ophthalmol"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2147\/OPTH.S4033","volume":"2","author":"TG Rotsos","year":"2008","unstructured":"Rotsos TG, Moschos MM. Cystoid macular edema. Clin Ophthalmol. 2008;2:919\u201330.","journal-title":"Clin Ophthalmol"},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, et al. Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res. 2018;63:20\u201368.","journal-title":"Prog Retin Eye Res"},{"key":"1313_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128811","volume":"10","author":"CD Haydinger","year":"2023","unstructured":"Haydinger CD, Ferreira LB, Williams KA, Smith JR. Mechanisms of macular edema. Front Med. 2023;10:1128811.","journal-title":"Front Med"},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.survophthal.2020.02.004","volume":"65","author":"G Holl\u00f3","year":"2020","unstructured":"Holl\u00f3 G, Aung T, Cantor LB, Aihara M. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol. 2020;65:496\u2013512.","journal-title":"Surv Ophthalmol"},{"key":"1313_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304283","volume":"19","author":"J Yao","year":"2024","unstructured":"Yao J, Huang W, Gao L, Liu Y, Zhang Q, He J, et al. Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: a network meta-analysis. PLoS ONE. 2024;19:e0304283.","journal-title":"PLoS ONE"},{"key":"1313_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00469-6","volume":"9","author":"GA Nassar","year":"2023","unstructured":"Nassar GA, Maqboul IM, El-Nahry AG, Hassan LM, Shalash AB. Macular vascular features of different types of diabetic macular edema using ocular coherence tomography angiography-a comparative study. Int J Retina Vitreous. 2023;9:32.","journal-title":"Int J Retina Vitreous"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01313-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:54:57Z","timestamp":1780307697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01313-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01313-0","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D. Y. Kim, None; J. H. Kim, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}